Sensus Healthcare Sells First SRT-100™ in Thailand
October 7th, 2010 1:19 am | Press Release
October 7, 2010
Boca Raton, FL
Asoke Skin Hospital of Bangkok has become the first healthcare facility in Thailand to successfully complete the installation and deployment of the SRT-100TM non-invasive skin cancer treatment system, officials with Sensus Healthcare announced today.
Thailand’s first and only specialized dermatologic and plastic surgery facility, Asoke Skin Hospital is a state-of-the art center providing a variety of skin care procedures, including hair and scalp solutions, skin cancer, and anti-aging treatments.
Sensus CEO, Mr. Joe Sardano, said the Asoke deployment represents the successful start of an aggressive marketing campaign to dermatologists and oncologists with a goal of expanding global adoption of the SRT-100™.
“As the Asoke success story illustrates, we expect clinicians to continue migrating toward the use of superficial radiotherapy as a safe and viable treatment option for non-melanoma skin cancers,” Sardano noted. “The SRT-100 holds tremendous promise to address a growing number of skin cancer cases around the world.”
FDA, UL and ISO/CE Mark certified, the SRT-100™ brings non-surgical skin cancer treatment to more patients in more settings. The SRT-100™ is a low dose radiotherapy option that greatly simplifies non-melanoma skin cancer treatment, with a time-efficient set-up procedure and a standard wall socket plug-in operation.
Delivering high cure rates and optimal cosmetic outcomes, the SRT-100™ addresses the most common form of cancer in the United States. It is estimated that up to 1.3 million new skin cancer cases are diagnosed annually in the U.S. alone, and over 2.5 million worldwide.
About Sensus Healthcare
Taking new aim at skin cancer, Sensus Healthcare is focused on the design, manufacture and marketing of products and services that incorporate proprietary mobile X-ray technology for cost-effective, non-invasive treatment of non-melanoma skin cancers. The signature Sensus Healthcare product, the SRT-100, meets stringent safety requirements set by the FDA, UL and ISO/CE Mark certification. Based in Boca Raton, Fla., Sensus employs best-practice standard operational procedures to ensure quality control, high-grade customer support, optimized success in field operations, and product reliability. For more information, visit www.sensushealthcare.com.
SENSUS MEDIA INQUIRIES:
The Benefits of SRT
Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:
- 95%+ cure rates that rival surgery
- No anesthesia, cutting, bleeding, stitching or pain
- No downtime or lifestyle restrictions
- Super cosmesis, no unsightly scarring
- No need for post-treatment reconstructive surgeries